---
title: "Are FBRX, LXFR, HUN, OLN Obtaining Fair Deals for their Shareholders?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294869552.md"
description: "Halper Sadeh LLC is investigating Forte Biosciences, Luxfer Holdings, Huntsman Corporation, and Olin Corporation for potential breaches of fiduciary duties related to their respective sale or merger transactions. The firm alleges insiders may receive unfair benefits and encourages shareholders to contact them to discuss rights and options on a contingent fee basis."
datetime: "2026-08-04T20:39:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294869552.md)
  - [en](https://longbridge.com/en/news/294869552.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294869552.md)
generator: "portal-rs"
---

# Are FBRX, LXFR, HUN, OLN Obtaining Fair Deals for their Shareholders?

***Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.***

***The proposed transactions may contain terms that could limit superior competing offers.***

***Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.***

NEW YORK, Aug. 4, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

**Forte Biosciences, Inc. ()'s** sale to argenx for $77.00 per share in cash. **If you are a Forte shareholder,** **click here to learn more about your rights and options****.**

**Luxfer Holdings PLC ()'s** sale to affiliates of Wynnchurch Capital, L.P. for $17.37 per ordinary share in cash. **If you are a Luxfer shareholder,** **click here to learn more about your legal rights and options**.

**Huntsman Corporation ()'s** sale to Olin Corporation for 0.5476 shares of Olin for each share of Huntsman. **If you are a Huntsman shareholder,** **click here to learn more about your legal rights and options**.

**Olin Corporation ()'s** merger with Huntsman Corporation. Upon closing of the proposed transaction, Olin shareholders will own approximately 54.5% of the combined company. **If you are an Olin shareholder,** **click here to learn more about your rights and options****.**

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLC

Daniel Sadeh, Esq.

Zachary Halper, Esq.

One World Trade Center

85th Floor

New York, NY 10007

(212) 763-0060

sadeh@halpersadeh.com

zhalper@halpersadeh.com

https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

### Related Stocks

- [HUN.US](https://longbridge.com/en/quote/HUN.US.md)
- [OLN.US](https://longbridge.com/en/quote/OLN.US.md)
- [LXFR.US](https://longbridge.com/en/quote/LXFR.US.md)
- [FBRX.US](https://longbridge.com/en/quote/FBRX.US.md)
- [ARGX.US](https://longbridge.com/en/quote/ARGX.US.md)
- [34962G208.US](https://longbridge.com/en/quote/34962G208.US.md)

## Related News & Research

- [Forte Biosciences seeks Nasdaq delisting, plans to end SEC reporting after merger closes](https://longbridge.com/en/news/297228231.md)
- [Huntsman Stockholders Approve Olin Merger Agreement at Special Meeting](https://longbridge.com/en/news/297136988.md)
- [18:29 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Olin Corporation - OLN](https://longbridge.com/en/news/297238765.md)
- [Forte Biosciences (NASDAQ:FBRX) Sees Strong Trading Volume  - What's Next?](https://longbridge.com/en/news/296380566.md)
- [argenx completes acquisition of Forte Biosciences for $77 per share](https://longbridge.com/en/news/297189309.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**